Department of Ophthalmology, The Third People's Hospital of Chengdu, The Affiliated Hospital of Southwest Jiaotong University, Chengdu, China.
Department of Ophthalmology, Eye and ENT Hospital of Fudan University; NHC Key Laboratory of Myopia; Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China.
Br J Ophthalmol. 2021 May;105(5):625-630. doi: 10.1136/bjophthalmol-2020-316144. Epub 2020 Jun 16.
To evaluate the changes in corneal endothelium cell density (ECD) and the correlated factors after Implantable Collamer Lens (ICL) V4c implantation.
In this retrospective, consecutive study, 48 eyes of 25 patients with myopia who underwent ICL V4c implantation were enrolled. Patients were followed up for at least 4 years, during which manifest refraction, uncorrected distance visual acuity, corrected distance visual acuity (CDVA), intraocular pressure, ECD, anterior chamber depth, anterior chamber volume (ACV), anterior chamber angle (ACA), vault and distance from the corneal endothelium to the central ICL (C-ICL) were measured. Spearman's correlation analysis was used to identify variables correlated with changes in ECD, and generalised estimating equation model adjusting within-patient intereye correlations was used to predict changes in ECD.
All surgeries were performed safely with no complications during follow-up (average 52±2.9 months). Safety and efficacy indices were 1.23±0.22 and 1.04±0.16, respectively. No eyes had decreased CDVA, and 67% gained one or more lines. Further, 79% were within ±0.50 D, and 100% were within ±1.0 D of the attempted refraction. Additionally, a 4.03%±2.2% reduction in ECD compared with the preoperative value was observed at the last follow-up visit. Changes in ECD were significantly correlated with vault, C-ICL, change in ACA and change in ACV. Vault was the most significant factor for changes in ECD.
ICL V4c implantation is safe and effective for myopia correction. Anterior segment biometric parameters including the vault, ACA and C-ICL may influence changes in ECD; specifically, the vault plays a major role.
评估 Implantable Collamer Lens(ICL)V4c 植入术后角膜内皮细胞密度(ECD)的变化及其相关因素。
本回顾性连续研究纳入了 25 名近视患者的 48 只眼,这些患者均接受了 ICL V4c 植入术。患者的随访时间至少为 4 年,在此期间测量了明显的屈光、未矫正的远视力、矫正的远视力(CDVA)、眼压、ECD、前房深度、前房容积(ACV)、前房角(ACA)、拱高和角膜内皮到中央 ICL(C-ICL)的距离。采用 Spearman 相关分析来确定与 ECD 变化相关的变量,并使用广义估计方程模型来调整患者内眼间的相关性,以预测 ECD 的变化。
所有手术均安全完成,随访期间无并发症(平均 52±2.9 个月)。安全性和有效性指数分别为 1.23±0.22 和 1.04±0.16。没有患者的 CDVA 下降,67%的患者提高了 1 行或更多。此外,79%的患者屈光度在±0.50 D 以内,100%的患者在±1.0 D 以内。此外,在最后一次随访时,ECD 较术前值下降了 4.03%±2.2%。ECD 的变化与拱高、C-ICL、ACA 的变化和 ACV 的变化显著相关。拱高是 ECD 变化的最显著因素。
ICL V4c 植入术治疗近视是安全有效的。包括拱高、ACA 和 C-ICL 在内的眼前节生物测量参数可能会影响 ECD 的变化;具体来说,拱高起着主要作用。